Tag: ablation

Boston Scientific to acquire Cryterion Medical

As part of its plan to expand it atrial fibrillation ablation therapy offering, Boston Scientific Corporation has announced a definitive agreement to acquire Cryterion...

Real-time lesion formation and gap detection during ablation: DURABLE-I follow-up

One-year results from the Dielectric Unravveling of RAdiofrequency ABLation Effectiveness (DURABLE-I) clinical trial have shown that the KODEX (Navix International Limited) system help to...

Boston Scientific announces acquisition of Securus Medical Group

Boston Scientific have announced the acquisition of Securus Medical Group, a privately-held company that has developed a thermal monitoring system for the continuous measurement...

Successful ablation for ventricular tachycardia associated with markedly reduced mortality in...

    Wendy Tzou (University of Colorado School of Medicine, Denver, USA) and colleagues at the International Ventricular Tachycardia Ablation Center Collaborative group (IVTCC) published two...
Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators described their findings in the Journal of the American College of Cardiology: Cardiovascular Imaging.

Biomarker predicts success of atrial fibrillation treatment

Written by Hannah Woolley, Cardiac Rhythm News Editor Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators...
Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology Lab at Johns Hopkins University (Baltimore, USA), as well as the Murray B Sachs professor in the Department of Biomedical Engineering and the university’s Institute for Computational Medicine. In this commentary, she discusses her research and the potentials of combining clinical imaging with computational modelling to create a unique virtual heart–one for every patient

Imaging-based simulations for predicting sudden death and guiding ablation

Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology...

Results of CASTLE-AF trial published: catheter ablation better than conventional drug...

The results of the CASTLE-AF study, published today in the New England Journal of Medicine, show that patients treated with radiofrequency catheter ablation rather than...

Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin 

The results of ABRIDGE-J, a Japanese multicentre randomised study on minimally interrupted dabigatran vs. uninterrupted warfarin for catheter ablation, were presented during a late-breaking...
imricor

Imricor announces completion of enrolment for MRI-guided ablations clinical study

Imricor Medical Systems announced today the completion of enrolment for the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Europe AF 2017

Five surprising messages from this year’s Europe AF

1. The "ILL-CONCEIVED" pallas study may be relaunched John Camm "I want to say just a few quick words about dronedarone", John Camm (St George's University of...

Biosense Webster launches Carto 3 system Carto Visitag module with Ablation...

Biosense Webster has launched of the Carto Visitag module with Ablation Index, a new technology providing visual indication based on the integration of power,...

AF ablation associated with phrenic nerve injury: Is this complication now...

Phrenic nerve injury is a well-established complication of all types of atrial fibrillation (AF) ablation and is most common with balloon-based approaches, writes Hugh...

US FDA approves Abbott’s FlexAbility Catheter, Sensor Enabled

The FlexAbility Ablation Catheter, Sensor Enabled is designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter. The Sensor Enabled...

Superior vena cava does not seem to contribute to long-standing persistent...

The arrhythmogenicity of the superior vena cava has been rarely detected in patients with long-standing persistent atrial fibrillation, according to study from China recently...

CardioFocus HeartLight Excalibur balloon undergoes initial clinical evaluation

CardioFocus has announced the initial clinical evaluation of the HeartLight Excalibur balloon, a next-generation technology designed for the treatment of atrial fibrillation. The device...

Discover the latest evidence and ablation techniques for persistent AF treatment

Join atrial fibrillation (AF) experts Prof Richard Schilling (St Barts Hospital, London UK), Prof Carlo de Asmundis (Universitair Ziekenhuis, Brussels, Belgium) and PD Dr...

King’s College London joins with Cambridge Design Partnership to further develop...

Cambridge Design Partnership recently announced it is working with Kings College London to further develop a new steerable catheter designed to treat complex cardiac...

Biosense Webster announces US launch of ThermoCool SmartTouch SF catheter

Biosense Webster has announced the US launch of the ThermoCool SmartTouch SF catheter. According to a company release, the catheter pairs contact force technology...